In another case of big pharma looking both beyond the pill and its traditional boundaries for alliances, AstraZeneca PLC has inked a basic agreement with Japan’s Omron Healthcare Inc. for a long-term global strategic collaboration for broad joint R&D into disease management solutions.
A just-signed memorandum of understanding with Kyoto-based Omron Healthcare - which the UK firm said “we hope will be the...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

